TY - JOUR
AU - Lovik, Anikó
AU - González-hijón, Juan
AU - Hoffart, Asle
AU - Fawns-Ritchie, Chloe
AU - Magnúsdóttir, Ingibjörg
AU - Lu, Li
AU - Unnarsdóttir, Anna Bára
AU - Kähler, Anna K.
AU - Campbell, Archie
AU - Hauksdóttir, Arna
AU - Chourpiliadis, Charilaos
AU - McCartney, Daniel L.
AU - Thordardottir, Edda Bjork
AU - Joyce, Emily E.
AU - Frans, Emma M.
AU - Jakobsdóttir, Jóhanna
AU - Trogstad, Lill
AU - Andreassen, Ole A.
AU - Magnus, Per Minor
AU - Johnson, Sverre Urnes
AU - Sullivan, Patrick F.
AU - Aspelund, Thor
AU - Porteous, David J.
AU - Ask, Helga
AU - Ebrahimi, Omid V.
AU - Valdimarsdóttir, Unnur A.
AU - Fang, Fang
PY - 2023
DA - September
TI - Elevated symptoms of depression and anxiety among family members and friends of critically ill COVID-19 patients – an observational study of five cohorts across four countries
JO - The Lancet Regional Health - Europe
DO - https://doi.org/10.1016/j.lanepe.2023.100733
AB - Background: Little is known regarding the mental health impact of having a significant person (family member and/or close friend) with COVID-19 of different severity. Methods: The study included five prospective cohorts from four countries (Iceland, Norway, Sweden, and the UK) with self-reported data on COVID-19 and symptoms of depression and anxiety during March 2020–March 2022. We calculated prevalence ratios (PR) of depression and anxiety in relation to having a significant person with COVID-19 and performed a longitudinal analysis in the Swedish cohort to describe temporal patterns. Findings: 162,237 and 168,783 individuals were included in the analysis of depression and anxiety, respectively, of whom 24,718 and 27,003 reported a significant person with COVID-19. Overall, the PR was 1.07 (95% CI: 1.05–1.10) for depression and 1.08 (95% CI: 1.03–1.13) for anxiety in relation to having a significant person with COVID-19. The respective PRs for depression and anxiety were 1.15 (95% CI: 1.08–1.23) and 1.24 (95% CI: 1.14–1.34) if the patient was hospitalized, 1.42 (95% CI: 1.27–1.57) and 1.45 (95% CI: 1.31–1.60) if the patient was ICU-admitted, and 1.34 (95% CI: 1.22–1.46) and 1.36 (95% CI: 1.22–1.51) if the patient died. Individuals with a significant person with hospitalized, ICU-admitted, or fatal COVID-19 showed elevated prevalence of depression and anxiety during the entire year after the COVID-19 diagnosis. Interpretation: Family members and close friends of critically ill COVID-19 patients show persistently elevated prevalence of depressive and anxiety symptoms.
PB - Science Direct
UR - https://discovery.dundee.ac.uk/en/publications/6f89ee17-3774-44df-b1a0-97b9fa9de2b0
KW - Coronavirus (COVID-19)
ER